BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22256867)

  • 1. Lack of association between ABCC2 gene variants and treatment response in epilepsy.
    Hilger E; Reinthaler EM; Stogmann E; Hotzy C; Pataraia E; Baumgartner C; Zimprich A; Zimprich F
    Pharmacogenomics; 2012 Jan; 13(2):185-90. PubMed ID: 22256867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
    Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
    Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
    J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy.
    Sporis D; Bozina N; Basić S; Lovrić M; Babić T; Susak I; Marković I
    Coll Antropol; 2013 Mar; 37(1):41-5. PubMed ID: 23697249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of ABCC1 and ABCC2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients.
    Au A; Baba AA; Azlan H; Norsa'adah B; Ankathil R
    J Clin Pharm Ther; 2014 Dec; 39(6):685-90. PubMed ID: 25060527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
    Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
    Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
    Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
    Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital.
    Subenthiran S; Abdullah NR; Joseph JP; Muniandy PK; Mok BT; Kee CC; Ismail Z; Mohamed Z
    PLoS One; 2013; 8(5):e64827. PubMed ID: 23717663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China.
    Zhao T; Li HJ; Zhang HL; Feng J; Yu J; Wang TT; Sun Y; Yu LH
    Ther Drug Monit; 2023 Feb; 45(1):117-125. PubMed ID: 36253887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.
    Ma CL; Wu XY; Jiao Z; Hong Z; Wu ZY; Zhong MK
    Pharmacogenomics; 2015; 16(4):347-60. PubMed ID: 25823783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy.
    Kwan P; Wong V; Ng PW; Lui CH; Sin NC; Wong KS; Baum L
    Pharmacogenomics; 2011 Mar; 12(3):319-25. PubMed ID: 21449672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCC2 haplotype is not associated with drug-resistant epilepsy.
    Seo T; Ishitsu T; Oniki K; Abe T; Shuto T; Nakagawa K
    J Pharm Pharmacol; 2008 May; 60(5):631-5. PubMed ID: 18416940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
    Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
    Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
    Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W
    Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
    Hoblinger A; Grunhage F; Sauerbruch T; Lammert F
    Digestion; 2009; 80(1):36-9. PubMed ID: 19451719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
    Nguyen TD; Markova S; Liu W; Gow JM; Baldwin RM; Habashian M; Relling MV; Ratain MJ; Kroetz DL
    Pharmacogenomics J; 2013 Oct; 13(5):396-402. PubMed ID: 22664480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
    Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
    PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.